ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 162 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2018. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $9,198,000 | -36.1% | 234,715 | +18.0% | 0.50% | -0.8% |
| Q1 2018 | $14,388,000 | -54.0% | 198,915 | -58.1% | 0.50% | -48.1% |
| Q4 2017 | $31,286,000 | -20.3% | 475,175 | -39.3% | 0.97% | +3.4% |
| Q3 2017 | $39,247,000 | -12.1% | 783,059 | -18.9% | 0.94% | -13.7% |
| Q2 2017 | $44,663,000 | +231.5% | 965,059 | +152.9% | 1.08% | +331.9% |
| Q1 2017 | $13,472,000 | +3.3% | 381,530 | -63.4% | 0.25% | +14.1% |
| Q4 2016 | $13,046,000 | -10.3% | 1,042,046 | -0.8% | 0.22% | -28.6% |
| Q3 2016 | $14,543,000 | +40.2% | 1,050,000 | 0.0% | 0.31% | +29.4% |
| Q2 2016 | $10,374,000 | -23.9% | 1,050,000 | +30.3% | 0.24% | +20.8% |
| Q1 2016 | $13,631,000 | -8.3% | 806,105 | +20.8% | 0.20% | +11.9% |
| Q4 2015 | $14,859,000 | +20.2% | 667,532 | +27.3% | 0.18% | +27.5% |
| Q3 2015 | $12,366,000 | – | 524,200 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |